Kymera Therapeutics Inc. (KYMR)
NASDAQ: KYMR
· Real-Time Price · USD
42.62
1.07 (2.58%)
At close: Aug 15, 2025, 3:59 PM
43.44
1.92%
After-hours: Aug 15, 2025, 05:03 PM EDT
Kymera Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 11.48M | 22.1M | 7.39M | 3.74M | 25.65M | 10.29M | 47.88M | 4.73M | 16.51M | 9.47M | 16.14M | 9.55M | 11.51M | 9.62M | 15.28M | 20.34M | 18.52M | 18.7M |
Cost of Revenue | 2.08M | 2.05M | 1.97M | 2M | n/a | n/a | n/a | 900K | 900K | 900K | 818K | 43.88M | 700K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 9.39M | 22.1M | 7.39M | 3.74M | 25.65M | 10.29M | 47.88M | 3.83M | 15.61M | 8.57M | 15.32M | -34.33M | 10.81M | 9.62M | 15.28M | 20.34M | 18.52M | 18.7M |
Operating Income | -84.56M | -74.43M | -80.75M | -72.12M | -50.92M | -57.83M | -19.31M | -57.51M | -43.38M | -45.33M | -38.63M | -44.88M | -40.81M | -36.93M | -33.99M | -28.64M | -24.73M | -13.17M |
Interest Income | 8.05M | 8.92M | 10.06M | 9.7M | 8.92M | 9.34M | 5M | 4.68M | 4.63M | 4.45M | 3.82M | 1.92M | 594K | 290K | 144K | 125K | 98K | 118K |
Pretax Income | -76.61M | -65.58M | -70.75M | -62.49M | -42.06M | -48.56M | -14.37M | -52.87M | -38.8M | -40.93M | -34.87M | -43M | -40.26M | -36.68M | -33.9M | -28.58M | -24.66M | -13.07M |
Net Income | -76.61M | -65.58M | -70.75M | -62.49M | -42.06M | -48.56M | -14.37M | -52.87M | -38.8M | -36.59M | -34.05M | -43M | -39.7M | -36.44M | -33.9M | -28.58M | -24.66M | -13.07M |
Selling & General & Admin | 17.64M | 16.27M | 16.33M | 15.46M | 17.37M | 14.37M | 14.23M | 14.12M | 14.13M | 12.56M | 11.64M | 10.56M | 11.03M | 10.61M | 11.74M | 10.67M | 8.03M | 5.91M |
Research & Development | 78.39M | 80.25M | 71.82M | 60.41M | 59.2M | 48.82M | 52.97M | 48.12M | 45.77M | 42.23M | 43.13M | 43.88M | 41.29M | 35.94M | 37.53M | 38.31M | 35.22M | 25.96M |
Other Expenses | -2.08M | n/a | n/a | n/a | n/a | 4.92M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 93.95M | 96.53M | 88.15M | 75.86M | 76.58M | 68.12M | 67.2M | 62.24M | 59.9M | 54.79M | 54.77M | 54.43M | 52.32M | 46.55M | 49.27M | 48.97M | 43.25M | 31.87M |
Interest Expense | 108K | 72K | 59K | 60K | 61K | 69K | 52K | 41K | 48K | 55K | 58K | 36K | 41K | 41K | 50K | 70K | 28K | 24K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 96.03M | 96.53M | 88.15M | 75.86M | 76.58M | 68.12M | 67.2M | 62.24M | 59.9M | 54.79M | 54.77M | 54.43M | 52.32M | 46.55M | 49.27M | 48.97M | 43.25M | 31.87M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.34M | -818K | n/a | -553K | -249K | 51K | 125K | 98K | 118K |
Shares Outstanding (Basic) | 80.45M | 80.15M | 79.99M | 76.13M | 73.06M | 70.77M | 58.52M | 58.42M | 58.33M | 58.19M | 57.89M | 54.54M | 51.77M | 51.65M | 51.39M | 50.71M | 45.09M | 44.65M |
Shares Outstanding (Diluted) | 80.45M | 80.15M | 79.99M | 76.13M | 73.06M | 70.77M | 58.52M | 58.42M | 58.33M | 58.19M | 57.89M | 54.54M | 51.77M | 51.65M | 51.39M | 50.71M | 45.09M | 44.65M |
EPS (Basic) | -0.95 | -0.82 | -0.88 | -0.82 | -0.58 | -0.69 | -0.25 | -0.9 | -0.67 | -0.63 | -0.59 | -0.79 | -0.77 | -0.71 | -0.66 | -0.56 | -0.55 | -0.29 |
EPS (Diluted) | -0.95 | -0.82 | -0.88 | -0.82 | -0.58 | -0.69 | -0.25 | -0.9 | -0.67 | -0.63 | -0.59 | -0.79 | -0.77 | -0.71 | -0.66 | -0.56 | -0.55 | -0.29 |
EBITDA | -84.56M | -63.46M | -68.71M | -60.44M | -40.06M | -47.03M | -13.45M | -51.93M | -37.85M | -39.97M | -33.99M | -42.2M | -39.52M | -35.94M | -33.16M | -27.84M | -24.08M | -12.57M |
EBIT | -76.51M | -65.51M | -70.69M | -62.43M | -42M | -48.49M | -14.32M | -52.83M | -38.75M | -40.87M | -34.81M | -42.97M | -40.22M | -36.64M | -33.85M | -28.51M | -24.63M | -13.05M |
Depreciation & Amortization | 2.08M | 2.05M | 1.99M | 1.99M | 1.94M | 1.46M | 865K | 900K | 900K | 900K | 818K | 767K | 1.3M | 977K | 689K | 671K | 552K | 485K |